Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | DY Dycom Industries Inc | 13G | 5.4% | Sep 30, 2026 | 39d |
| American Century Investment Management, Inc. | VC Visteon Corp | 13G/A | 10.2% | Sep 30, 2026 | 39d |
| FMR LLC | PVH Pvh Corp. | 13G/A | 9.5% | Sep 30, 2026 | 39d |
| T. Rowe Price Investment Management, Inc. | BCAX Bicara Therapeutics Inc. | 13G/A | 4.2% | Sep 30, 2026 | 39d |
| Allspring Global Investments Holdings, LLC | MATV Mativ Holdings, Inc. | 13G/A | 6.3% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G | 39.19% | Sep 30, 2026 | 39d |
| ALPS ADVISORS INC | HESM Hess Midstream LP | 13G/A | 23.51% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 44.74% | Sep 30, 2026 | 39d |
| PRICE T ROWE ASSOCIATES INC /MD/ | AIV Apartment Investment & Management Co | 13G/A | 3.5% | Sep 30, 2026 | 39d |
| WOLVERINE ASSET MANAGEMENT LLC | BDCI BTC Development Corp. | 13G | 5.75% | Sep 30, 2026 | 39d |
| FMR LLC | IMCR Immunocore Holdings plc | 13G/A | 3.6% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 3.98% | Sep 30, 2026 | 39d |
| ALPS ADVISORS INC | WES Western Midstream Partners, LP | 13G/A | 9.04% | Sep 30, 2026 | 39d |
| FEDERATED HERMES, INC. | LFMD LifeMD, Inc. | 13G/A | 8.4% | Sep 30, 2026 | 39d |
| WASATCH ADVISORS LP | GSHD Goosehead Insurance, Inc. | 13G/A | 10.2% | Sep 30, 2026 | 39d |
| FMR LLC | EXLS ExlService Holdings, Inc. | 13G/A | 12% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 39.59% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G | 41.04% | Sep 30, 2026 | 39d |
| FMR LLC | DOO BRP Inc. | 13G/A | 11.6% | Sep 30, 2026 | 39d |
| ALPS ADVISORS INC | SUN Sunoco LP | 13G/A | 11.39% | Sep 30, 2026 | 39d |
| BROWN ADVISORY INC | ANDG Andersen Group Inc. | 13G/A | 10.72% | Sep 30, 2026 | 39d |
| Global X Management CO LLC | CMCO Columbus Mckinnon Corp | 13G/A | 10.27% | Sep 30, 2026 | 39d |
| Nantahala Capital Management, LLC | RACC Research Alliance Corp III | 13G | 14.1% | Sep 30, 2026 | 39d |
| WOLVERINE ASSET MANAGEMENT LLC | DBCA D. Boral Acquisition I Corp. | 13G | 5.12% | Sep 30, 2026 | 39d |
| WOLVERINE ASSET MANAGEMENT LLC | BID Tribeca Strategic Acquisition Corp. | 13G | 5.88% | Sep 30, 2026 | 39d |
| Allspring Global Investments Holdings, LLC | EVER EverQuote, Inc. | 13G | 5.9% | Sep 30, 2026 | 39d |
| PRUDENTIAL FINANCIAL INC | NHP National Healthcare Properties, Inc. | 13G/A | 3.1% | Sep 30, 2026 | 39d |
| ATW Growth Opportunities SPV, LLC | SRTM Stratum Holdings Corp. | 13G/A | 9.9% | Sep 30, 2026 | 39d |
| T. Rowe Price Investment Management, Inc. | ESAB ESAB Corp | 13G/A | 6.2% | Sep 30, 2026 | 39d |
| FMR LLC | NXPI NXP Semiconductors N.V. | 13G/A | 3.7% | Sep 30, 2026 | 39d |
| STATE STREET CORP | TTD Trade Desk, Inc. | 13G | 3.3% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 6.1% | Sep 30, 2026 | 39d |
| ARK Investment Management LLC | TXG 10x Genomics, Inc. | 13G/A | 5.22% | Sep 30, 2026 | 39d |
| FRANKLIN RESOURCES INC | LUV Southwest Airlines Co | 13G/A | 10.2% | Sep 30, 2026 | 39d |
| BANK OF AMERICA CORP /DE/ | ACH Accendra Health Inc | 13G | 10.8% | Sep 30, 2026 | 39d |
| FMR LLC | ON On Semiconductor Corp | 13G/A | 8.2% | Sep 30, 2026 | 39d |
| FMR LLC | PRSU Pursuit Attractions & Hospitality, Inc. | 13G/A | 10.7% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 16.3% | Sep 30, 2026 | 39d |
| PRUDENTIAL FINANCIAL INC | NGNE Neurogene Inc. | 13G | 11.2% | Sep 30, 2026 | 39d |
| Commodore Capital LP | SGMT Sagimet Biosciences Inc. | 13G | 7.6% | Sep 30, 2026 | 39d |
| FMR LLC | KRSA Korsana Biosciences, Inc. | 13G/A | 6.9% | Sep 30, 2026 | 39d |
| PRICE T ROWE ASSOCIATES INC /MD/ | BBNX Beta Bionics, Inc. | 13G | 16.6% | Sep 30, 2026 | 39d |
| Taylor Mark Andrew | CDT CDT Equity Inc. | 13G/A | 3.4% | Sep 30, 2026 | 39d |
| FMR LLC | BWIN Baldwin Insurance Group, Inc. | 13G/A | 3% | Sep 30, 2026 | 39d |
| Orca Capital AG | NCI Neo-Concept International Group Holdings Ltd | 13G | 9.9% | Sep 30, 2026 | 39d |
| PRICE T ROWE ASSOCIATES INC /MD/ | RVTY Revvity, Inc. | 13G/A | 11.8% | Sep 30, 2026 | 39d |
| ALPS ADVISORS INC | GEL Genesis Energy LP | 13G/A | 20.98% | Sep 30, 2026 | 39d |
| T. Rowe Price Investment Management, Inc. | BANC Banc Of California, Inc. | 13G/A | 10.1% | Sep 30, 2026 | 39d |
| First Trust Portfolios L.P. | BUYZ Franklin Templeton ETF Trust | 13G/A | 10.02% | Sep 30, 2026 | 39d |
| FEDERATED HERMES, INC. | ARCT Arcturus Therapeutics Holdings Inc. | 13G/A | 5.9% | Sep 30, 2026 | 39d |